# Elutia to Present at Planet MicroCap Showcase 2026 on June 17th
Canonical URL: https://biopharmsignal.com/news/AZYO/elutia-to-present-at-planet-microcap-showcase-2026-on-june-17th
Ticker: AZYO
Company: Aziyo Biologics
Source: Aziyo Biologics
Published: 2026-06-25 13:46 EST
Original Source URL: https://investors.elutia.com
## Summary

GAITHERSBURG, Md., June 11, 2026 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) ("Elutia" or the "Company"), a pioneer in drug-eluting biomatrix technologies, today announced that Dr. Randy Mills, Chief Executive Officer, and Dr. Michelle Williams, Chief Scientific Officer, will present and host

## Article Body
GAITHERSBURG, Md., June 11, 2026 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) ("Elutia" or the "Company"), a pioneer in drug-eluting biomatrix technologies, today announced that Dr. Randy Mills, Chief Executive Officer, and Dr. Michelle Williams, Chief Scientific Officer, will present and host
## Recent Company News
- 2026-06-25 13:46 EST — [Elutia to Present at Planet MicroCap Showcase 2026 on June 17th](https://biopharmsignal.com/news/AZYO/elutia-to-present-at-planet-microcap-showcase-2026-on-june-17th) — Source: Aziyo Biologics
- 2026-06-25 13:46 EST — [Elutia Reports First Quarter 2026 Results and Highlights NXT-41x Progress Toward $1.5 Billion U.S. Plastic and Reconstructive Surgery Market](https://biopharmsignal.com/news/AZYO/elutia-reports-first-quarter-2026-results-and-highlights-nxt-41x-progress-toward-1-5-billion-u-s-plastic-and-reconstructive-surgery-market) — Source: Aziyo Biologics
- 2026-06-25 13:46 EST — [Elutia to Present at the 16th Annual LD Micro Invitational on May 18th](https://biopharmsignal.com/news/AZYO/elutia-to-present-at-the-16th-annual-ld-micro-invitational-on-may-18th) — Source: Aziyo Biologics
- 2026-06-25 13:46 EST — [Elutia to Present at Global BioInnovation Forum on NXT-41x Biomatrix Program for Plastic and Reconstructive Surgery](https://biopharmsignal.com/news/AZYO/elutia-to-present-at-global-bioinnovation-forum-on-nxt-41x-biomatrix-program-for-plastic-and-reconstructive-surgery) — Source: Aziyo Biologics
- 2026-06-25 13:46 EST — [Elutia Reports Preliminary Fourth Quarter 2025 Results, Strengthened Financial Position, and Upcoming NXT-41x Milestones](https://biopharmsignal.com/news/AZYO/elutia-reports-preliminary-fourth-quarter-2025-results-strengthened-financial-position-and-upcoming-nxt-41x-milestones) — Source: Aziyo Biologics
## Related News
- 2026-07-21 12:00 EST — MOR — [Novartis delivered sales growth in Q2 and further advanced the pipeline; Full-year guidance reaffirmed](https://biopharmsignal.com/news/MOR/novartis-delivered-sales-growth-in-q2-and-further-advanced-the-pipeline-full-yea-63a32b47)
- 2026-07-20 20:05 EST — RANI — [Rani Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/RANI/rani-therapeutics-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4-ec56b3b0)
- 2026-07-20 14:53 EST — IPHA — [Innate Pharma announces Completion of Enrollment in Phase 1 Dose Escalation Study of IPH4502, a Novel Nectin-4 Exatecan Antibody-Drug Conjugate (ADC)](https://biopharmsignal.com/news/IPHA/innate-pharma-announces-completion-of-enrollment-in-phase-1-dose-escalation-stud-0778493f)
- 2026-07-20 13:05 EST — ACAD — [Acadia Pharmaceuticals Receives FDA Fast Track Designation for Remlifanserin in Alzheimer's Disease Psychosis](https://biopharmsignal.com/news/ACAD/acadia-pharmaceuticals-receives-fda-fast-track-designation-for-remlifanserin-in--f36b622c)
- 2026-07-20 13:00 EST — ENLV — [Enlivex Treasury Portfolio Update: NAV Per Ordinary Share $66.16; Total Treasury Holdings Valued at Approximately $1.1 Billion](https://biopharmsignal.com/news/ENLV/enlivex-treasury-portfolio-update-nav-per-ordinary-share-66-16-total-treasury-ho-9d036ef9)